Honeywell International Inc.
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
|
22-2640650
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
115 Tabor Road
Morris Plains, New Jersey
|
|
07950
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
(973) 455-2000
|
|
|
(Registrant’s telephone number, including area code)
|
|
|
|
|
|
Not Applicable
|
|
|
(Former name, former address and former fiscal year,
if changed since last report)
|
|
Large accelerated filer
x
|
|
Accelerated filer
o
|
Non-Accelerated filer
o
|
|
Smaller reporting company
o
|
|
|
Emerging growth company
o
|
|
Page No.
|
||
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|
||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
|
(Dollars in millions, except per share amounts)
|
||||||
Product sales
|
$
|
6,713
|
|
|
$
|
8,234
|
|
Service sales
|
2,171
|
|
|
2,158
|
|
||
Net sales
|
8,884
|
|
|
10,392
|
|
||
Costs, expenses and other
|
|
|
|
||||
Cost of products sold
|
4,622
|
|
|
5,905
|
|
||
Cost of services sold
|
1,257
|
|
|
1,286
|
|
||
|
5,879
|
|
|
7,191
|
|
||
Selling, general and administrative expenses
|
1,363
|
|
|
1,475
|
|
||
Other (income) expense
|
(285
|
)
|
|
(268
|
)
|
||
Interest and other financial charges
|
85
|
|
|
83
|
|
||
|
7,042
|
|
|
8,481
|
|
||
Income before taxes
|
1,842
|
|
|
1,911
|
|
||
Tax expense
|
406
|
|
|
459
|
|
||
Net income
|
1,436
|
|
|
1,452
|
|
||
Less: Net income attributable to the noncontrolling interest
|
20
|
|
|
13
|
|
||
Net income attributable to Honeywell
|
$
|
1,416
|
|
|
$
|
1,439
|
|
Earnings per share of common stock - basic
|
$
|
1.94
|
|
|
$
|
1.92
|
|
Earnings per share of common stock - assuming dilution
|
$
|
1.92
|
|
|
$
|
1.89
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
|
(Dollars in millions)
|
||||||
Net income
|
$
|
1,436
|
|
|
$
|
1,452
|
|
Other comprehensive income (loss), net of tax
|
|
|
|
||||
Foreign exchange translation adjustment
|
205
|
|
|
91
|
|
||
|
|
|
|
||||
Actuarial (gains) losses recognized
|
—
|
|
|
2
|
|
||
Prior service (credit) cost recognized
|
(19
|
)
|
|
(18
|
)
|
||
Pension and other postretirement benefits adjustments
|
(19
|
)
|
|
(16
|
)
|
||
|
|
|
|
||||
Cash flow hedges recognized in other comprehensive income (loss)
|
38
|
|
|
(32
|
)
|
||
Less: Reclassification adjustment for gains (losses) included in net income
|
32
|
|
|
(18
|
)
|
||
Changes in fair value of cash flow hedges
|
6
|
|
|
(14
|
)
|
||
Other comprehensive income (loss), net of tax
|
192
|
|
|
61
|
|
||
Comprehensive income
|
1,628
|
|
|
1,513
|
|
||
Less: Comprehensive income attributable to the noncontrolling interest
|
24
|
|
|
18
|
|
||
Comprehensive income attributable to Honeywell
|
$
|
1,604
|
|
|
$
|
1,495
|
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
(Dollars in millions)
|
||||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
|
|
||
Cash and cash equivalents
|
$
|
8,625
|
|
|
$
|
9,287
|
|
Short-term investments
|
2,059
|
|
|
1,623
|
|
||
Accounts receivable - net
|
7,307
|
|
|
7,508
|
|
||
Inventories
|
4,548
|
|
|
4,326
|
|
||
Other current assets
|
1,795
|
|
|
1,618
|
|
||
Total current assets
|
24,334
|
|
|
24,362
|
|
||
Investments and long-term receivables
|
747
|
|
|
742
|
|
||
Property, plant and equipment - net
|
5,276
|
|
|
5,296
|
|
||
Goodwill
|
15,555
|
|
|
15,546
|
|
||
Other intangible assets - net
|
4,039
|
|
|
4,139
|
|
||
Insurance recoveries for asbestos related liabilities
|
429
|
|
|
437
|
|
||
Deferred income taxes
|
362
|
|
|
382
|
|
||
Other assets
|
7,818
|
|
|
6,869
|
|
||
Total assets
|
$
|
58,560
|
|
|
$
|
57,773
|
|
LIABILITIES
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
5,582
|
|
|
$
|
5,607
|
|
Commercial paper and other short-term borrowings
|
3,514
|
|
|
3,586
|
|
||
Current maturities of long-term debt
|
4,000
|
|
|
2,872
|
|
||
Accrued liabilities
|
6,497
|
|
|
6,859
|
|
||
Total current liabilities
|
19,593
|
|
|
18,924
|
|
||
Long-term debt
|
8,598
|
|
|
9,756
|
|
||
Deferred income taxes
|
1,850
|
|
|
1,713
|
|
||
Postretirement benefit obligations other than pensions
|
333
|
|
|
344
|
|
||
Asbestos related liabilities
|
2,246
|
|
|
2,269
|
|
||
Other liabilities
|
6,977
|
|
|
6,402
|
|
||
Redeemable noncontrolling interest
|
7
|
|
|
7
|
|
||
SHAREOWNERS’ EQUITY
|
|
|
|
||||
Capital - common stock issued
|
958
|
|
|
958
|
|
||
- additional paid-in capital
|
6,652
|
|
|
6,452
|
|
||
Common stock held in treasury, at cost
|
(20,392
|
)
|
|
(19,771
|
)
|
||
Accumulated other comprehensive loss
|
(3,245
|
)
|
|
(3,437
|
)
|
||
Retained earnings
|
34,794
|
|
|
33,978
|
|
||
Total Honeywell shareowners’ equity
|
18,767
|
|
|
18,180
|
|
||
Noncontrolling interest
|
189
|
|
|
178
|
|
||
Total shareowners’ equity
|
18,956
|
|
|
18,358
|
|
||
Total liabilities, redeemable noncontrolling interest and shareowners’ equity
|
$
|
58,560
|
|
|
$
|
57,773
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
|
(Dollars in millions)
|
||||||
Cash flows from operating activities:
|
|
|
|
|
|
||
Net income
|
$
|
1,436
|
|
|
$
|
1,452
|
|
Less: Net income attributable to the noncontrolling interest
|
20
|
|
|
13
|
|
||
Net income attributable to Honeywell
|
1,416
|
|
|
1,439
|
|
||
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities:
|
|
|
|
||||
Depreciation
|
163
|
|
|
179
|
|
||
Amortization
|
98
|
|
|
109
|
|
||
Repositioning and other charges
|
84
|
|
|
191
|
|
||
Net payments for repositioning and other charges
|
(34
|
)
|
|
(141
|
)
|
||
Pension and other postretirement income
|
(163
|
)
|
|
(254
|
)
|
||
Pension and other postretirement benefit payments
|
(30
|
)
|
|
(36
|
)
|
||
Stock compensation expense
|
41
|
|
|
52
|
|
||
Deferred income taxes
|
80
|
|
|
47
|
|
||
Other
|
(4
|
)
|
|
2
|
|
||
Changes in assets and liabilities, net of the effects of acquisitions and divestitures:
|
|
|
|
||||
Accounts receivable
|
198
|
|
|
(61
|
)
|
||
Inventories
|
(221
|
)
|
|
(163
|
)
|
||
Other current assets
|
(217
|
)
|
|
(43
|
)
|
||
Accounts payable
|
(29
|
)
|
|
57
|
|
||
Accrued liabilities
|
(248
|
)
|
|
(242
|
)
|
||
Net cash provided by operating activities
|
1,134
|
|
|
1,136
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Expenditures for property, plant and equipment
|
(141
|
)
|
|
(140
|
)
|
||
Proceeds from disposals of property, plant and equipment
|
2
|
|
|
2
|
|
||
Increase in investments
|
(1,226
|
)
|
|
(583
|
)
|
||
Decrease in investments
|
796
|
|
|
1,838
|
|
||
Other
|
(40
|
)
|
|
(123
|
)
|
||
Net cash (used for) provided by investing activities
|
(609
|
)
|
|
994
|
|
||
Cash flows from financing activities:
|
|
|
|
||||
Proceeds from issuance of commercial paper and other short-term borrowings
|
3,318
|
|
|
6,676
|
|
||
Payments of commercial paper and other short-term borrowings
|
(3,319
|
)
|
|
(5,329
|
)
|
||
Proceeds from issuance of common stock
|
145
|
|
|
60
|
|
||
Proceeds from issuance of long-term debt
|
20
|
|
|
3
|
|
||
Payments of long-term debt
|
(13
|
)
|
|
(1,246
|
)
|
||
Repurchases of common stock
|
(750
|
)
|
|
(940
|
)
|
||
Cash dividends paid
|
(606
|
)
|
|
(556
|
)
|
||
Other
|
(30
|
)
|
|
(116
|
)
|
||
Net cash used for financing activities
|
(1,235
|
)
|
|
(1,448
|
)
|
||
Effect of foreign exchange rate changes on cash and cash equivalents
|
48
|
|
|
156
|
|
||
Net (decrease) increase in cash and cash equivalents
|
(662
|
)
|
|
838
|
|
||
Cash and cash equivalents at beginning of period
|
9,287
|
|
|
7,059
|
|
||
Cash and cash equivalents at end of period
|
$
|
8,625
|
|
|
7,897
|
|
|
Three Months Ended March 31,
|
||||||||||||
2019
|
|
2018
|
|||||||||||
Shares
|
|
$
|
|
Shares
|
|
$
|
|||||||
|
(Dollars in millions, except per share amounts)
|
||||||||||||
Common stock, par value
|
957.6
|
|
|
958
|
|
|
957.6
|
|
|
958
|
|
||
Additional paid-in capital
|
|
|
|
|
|
|
|
||||||
Beginning balance
|
|
|
6,452
|
|
|
|
|
6,212
|
|
||||
Issued for employee savings and option plans
|
|
|
159
|
|
|
|
|
(14
|
)
|
||||
Stock-based compensation expense
|
|
|
41
|
|
|
|
|
52
|
|
||||
Ending balance
|
|
|
6,652
|
|
|
|
|
6,250
|
|
||||
Treasury stock
|
|
|
|
|
|
|
|
||||||
Beginning balance
|
(228.0
|
)
|
|
(19,771
|
)
|
|
(206.7
|
)
|
|
(15,914
|
)
|
||
Reacquired stock or repurchases of common stock
|
(5.1
|
)
|
|
(750
|
)
|
|
(6.1
|
)
|
|
(940
|
)
|
||
Issued for employee savings and option plans
|
3.2
|
|
|
129
|
|
|
2.1
|
|
|
20
|
|
||
Ending balance
|
(229.9
|
)
|
|
(20,392
|
)
|
|
(210.7
|
)
|
|
(16,834
|
)
|
||
Retained earnings
|
|
|
|
|
|
|
|
||||||
Beginning balance
|
|
|
33,978
|
|
|
|
|
27,481
|
|
||||
Adoption of new accounting standards
|
|
|
—
|
|
|
|
|
264
|
|
||||
Net income attributable to Honeywell
|
|
|
1,416
|
|
|
|
|
1,439
|
|
||||
Dividends on common stock
|
|
|
(600
|
)
|
|
|
|
(561
|
)
|
||||
Ending balance
|
|
|
34,794
|
|
|
|
|
28,623
|
|
||||
Accumulated other comprehensive income (loss)
|
|
|
|
|
|
|
|
||||||
Beginning balance
|
|
|
(3,437
|
)
|
|
|
|
(2,235
|
)
|
||||
Foreign exchange translation adjustment
|
|
|
205
|
|
|
|
|
91
|
|
||||
Pensions and other postretirement benefit adjustments
|
|
|
(19
|
)
|
|
|
|
(16
|
)
|
||||
Changes in fair value of cash flow hedges
|
|
|
6
|
|
|
|
|
(14
|
)
|
||||
Ending balance
|
|
|
(3,245
|
)
|
|
|
|
(2,174
|
)
|
||||
Noncontrolling interest
|
|
|
|
|
|
|
|
||||||
Beginning balance
|
|
|
178
|
|
|
|
|
163
|
|
||||
Acquisitions, divestitures, and other
|
|
|
—
|
|
|
|
|
1
|
|
||||
Net income attributable to noncontrolling interest
|
|
|
20
|
|
|
|
|
14
|
|
||||
Foreign exchange translation adjustment
|
|
|
4
|
|
|
|
|
4
|
|
||||
Dividends paid
|
|
|
(13
|
)
|
|
|
|
(3
|
)
|
||||
Ending balance
|
|
|
189
|
|
|
|
|
179
|
|
||||
Total shareowners' equity
|
727.7
|
|
|
18,956
|
|
|
746.9
|
|
|
17,002
|
|
||
Cash dividends per share of common stock
|
|
|
$
|
0.820
|
|
|
|
|
$
|
0.745
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
Severance
|
$
|
31
|
|
|
$
|
31
|
|
Asset impairments
|
11
|
|
|
47
|
|
||
Exit costs
|
18
|
|
|
8
|
|
||
Reserve adjustments
|
(2
|
)
|
|
(1
|
)
|
||
Total net repositioning charge
|
58
|
|
|
85
|
|
||
Asbestos related litigation charges, net of insurance and indemnities
|
11
|
|
|
49
|
|
||
Probable and reasonably estimable environmental liabilities, net of indemnities
|
14
|
|
|
57
|
|
||
Other
|
1
|
|
|
—
|
|
||
Total net repositioning and other charges
|
$
|
84
|
|
|
$
|
191
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
Cost of products and services sold
|
$
|
55
|
|
|
$
|
128
|
|
Selling, general and administrative expenses
|
29
|
|
|
22
|
|
||
Other (income) expense
|
—
|
|
|
41
|
|
||
|
$
|
84
|
|
|
$
|
191
|
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
Aerospace
|
$
|
16
|
|
|
$
|
68
|
|
Honeywell Building Technologies
|
8
|
|
|
4
|
|
||
Performance Materials and Technologies
|
(1
|
)
|
|
4
|
|
||
Safety and Productivity Solutions
|
5
|
|
|
7
|
|
||
Corporate
|
56
|
|
|
108
|
|
||
|
$
|
84
|
|
|
$
|
191
|
|
|
Severance
Costs
|
|
Asset
Impairments
|
|
Exit
Costs
|
|
Total
|
||||||||
December 31, 2018
|
$
|
489
|
|
|
$
|
—
|
|
|
$
|
77
|
|
|
$
|
566
|
|
Charges
|
31
|
|
|
11
|
|
|
18
|
|
|
60
|
|
||||
Usage - cash
|
(35
|
)
|
|
—
|
|
|
(9
|
)
|
|
(44
|
)
|
||||
Usage - noncash
|
—
|
|
|
(11
|
)
|
|
—
|
|
|
(11
|
)
|
||||
Foreign currency translation
|
1
|
|
|
—
|
|
|
—
|
|
|
1
|
|
||||
Adjustments
|
(1
|
)
|
|
—
|
|
|
(1
|
)
|
|
(2
|
)
|
||||
March 31, 2019
|
$
|
485
|
|
|
$
|
—
|
|
|
$
|
85
|
|
|
$
|
570
|
|
|
Three Months Ended March 31,
|
||||
|
2019
|
|
2018
|
||
Interest income
|
(67
|
)
|
|
(50
|
)
|
Pension ongoing income – non-service
|
(184
|
)
|
|
(304
|
)
|
Other postretirement income – non-service
|
(12
|
)
|
|
(6
|
)
|
Equity income of affiliated companies
|
(9
|
)
|
|
(11
|
)
|
Foreign exchange
|
(11
|
)
|
|
(1
|
)
|
Separation costs
|
—
|
|
|
55
|
|
Other (net)
|
(2
|
)
|
|
49
|
|
|
(285
|
)
|
|
(268
|
)
|
|
Three Months Ended March 31,
|
||||||
Basic
|
2019
|
|
2018
|
||||
Net income attributable to Honeywell
|
$
|
1,416
|
|
|
$
|
1,439
|
|
Weighted average shares outstanding
|
729.7
|
|
|
750.6
|
|
||
Earnings per share of common stock
|
$
|
1.94
|
|
|
$
|
1.92
|
|
|
Three Months Ended March 31,
|
||||||
Assuming Dilution
|
2019
|
|
2018
|
||||
Net income attributable to Honeywell
|
$
|
1,416
|
|
|
$
|
1,439
|
|
Average Shares
|
|
|
|
||||
Weighted average shares outstanding
|
729.7
|
|
|
750.6
|
|
||
Dilutive securities issuable - stock plans
|
9.1
|
|
|
10.4
|
|
||
Total weighted average shares outstanding
|
738.8
|
|
|
761.0
|
|
||
Earnings per share of common stock
|
$
|
1.92
|
|
|
$
|
1.89
|
|
|
Three Months Ended
March 31,
|
||||||
|
2019
|
|
2018
|
||||
Aerospace
|
|
|
|
||||
Commercial Aviation Original Equipment
|
$
|
759
|
|
|
$
|
695
|
|
Commercial Aviation Aftermarket
|
1,361
|
|
|
1,268
|
|
||
Defense and Space
|
1,221
|
|
|
1,086
|
|
||
Transportation Systems
|
—
|
|
|
928
|
|
||
|
3,341
|
|
|
3,977
|
|
||
Honeywell Building Technologies
|
|
|
|
||||
Homes Products and Software
|
—
|
|
|
519
|
|
||
Distribution (ADI)
|
—
|
|
|
638
|
|
||
Products
|
810
|
|
|
714
|
|
||
Building Solutions
|
579
|
|
|
562
|
|
||
|
1,389
|
|
|
2,433
|
|
||
Performance Materials and Technologies
|
|
|
|
||||
UOP
|
610
|
|
|
612
|
|
||
Process Solutions
|
1,246
|
|
|
1,214
|
|
||
Specialty Products
|
269
|
|
|
277
|
|
||
Fluorine Products
|
447
|
|
|
431
|
|
||
|
2,572
|
|
|
2,534
|
|
||
Safety and Productivity Solutions
|
|
|
|
||||
Safety and Retail
|
538
|
|
|
551
|
|
||
Productivity Products
|
271
|
|
|
329
|
|
||
Warehouse and Workflow Solutions
|
558
|
|
|
367
|
|
||
Sensing & Internet-of-Things (IoT)
|
215
|
|
|
201
|
|
||
|
1,582
|
|
|
1,448
|
|
||
Net sales
|
$
|
8,884
|
|
|
$
|
10,392
|
|
|
Three Months Ended March 31,
|
||||
|
2019
|
|
2018
|
||
Products, transferred point in time
|
61
|
%
|
|
69
|
%
|
Products, transferred over time
|
15
|
|
|
10
|
|
Net product sales
|
76
|
|
|
79
|
|
Services, transferred point in time
|
9
|
|
|
7
|
|
Services, transferred over time
|
15
|
|
|
14
|
|
Net service sales
|
24
|
|
|
21
|
|
Net sales
|
100
|
%
|
|
100
|
%
|
|
2019
|
|
2018
|
||||
Contract assets - Beginning period
|
$
|
1,548
|
|
|
$
|
1,721
|
|
Contract assets - March 31
|
1,700
|
|
|
1,672
|
|
||
Change in contract assets - increase (decrease)
|
$
|
152
|
|
|
$
|
(49
|
)
|
|
|
|
|
||||
Contract liabilities - Beginning period
|
$
|
(3,378
|
)
|
|
$
|
(2,973
|
)
|
Contract liabilities - March 31
|
(3,426
|
)
|
|
(3,081
|
)
|
||
Change in contract liabilities - (increase) decrease
|
$
|
(48
|
)
|
|
$
|
(108
|
)
|
|
|
|
|
||||
Net change
|
$
|
104
|
|
|
$
|
(157
|
)
|
|
March 31, 2019
|
||
Aerospace
|
$
|
10,890
|
|
Honeywell Building Technologies
|
5,657
|
|
|
Performance Materials and Technologies
|
6,347
|
|
|
Safety and Productivity Solutions
|
1,850
|
|
|
|
$
|
24,744
|
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
Trade
|
$
|
7,499
|
|
|
$
|
7,705
|
|
Less - Allowance for doubtful accounts
|
(192
|
)
|
|
(197
|
)
|
||
|
$
|
7,307
|
|
|
$
|
7,508
|
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
Raw materials
|
$
|
1,170
|
|
|
$
|
1,109
|
|
Work in process
|
847
|
|
|
811
|
|
||
Finished products
|
2,577
|
|
|
2,445
|
|
||
|
4,594
|
|
|
4,365
|
|
||
Reduction to LIFO cost basis
|
(46
|
)
|
|
(39
|
)
|
||
|
$
|
4,548
|
|
|
$
|
4,326
|
|
|
Three Months Ended
March 31, 2019 |
||
Operating lease cost
|
$
|
54
|
|
Variable lease cost
|
8
|
|
|
Short-term lease cost
|
3
|
|
|
Financing lease cost:
|
|
||
Amortization of right-of-use assets
|
14
|
|
|
Interest on lease liability
|
8
|
|
|
Total financing lease cost
|
22
|
|
|
Total lease cost
|
$
|
87
|
|
|
Three Months Ended
March 31, 2019 |
||
Cash paid for amounts included in the measurement of lease liabilities:
|
|
|
|
Operating cash flows from operating leases
|
$
|
61
|
|
Operating cash flows from finance leases
|
1
|
|
|
Financing cash flows from finance leases
|
10
|
|
|
Right-of-use assets obtained in exchange for lease obligations:
|
|
||
Operating leases
|
$
|
10
|
|
Finance leases
|
4
|
|
|
March 31, 2019
|
||
Operating leases
|
|
||
Other assets
|
$
|
669
|
|
Accrued liabilities
|
177
|
|
|
Other liabilities
|
527
|
|
|
Total operating lease liabilities
|
$
|
704
|
|
Financing leases
|
|
||
Property, plant and equipment
|
$
|
313
|
|
Accumulated depreciation
|
(100
|
)
|
|
Property, plant and equipment - net
|
$
|
213
|
|
Current maturities of long-term debt
|
51
|
|
|
Long-term debt
|
162
|
|
|
Total financing lease liabilities
|
$
|
213
|
|
Weighted-average remaining lease term
|
|
||
Operating leases
|
6 years
|
|
|
Financing leases
|
5 years
|
|
|
Weighted-average discount rate
|
|
||
Operating leases
|
3.2
|
%
|
|
Financing leases
|
17.0
|
%
|
|
Operating Leases
|
Financing Leases
|
||||
2019
|
$
|
161
|
|
$
|
61
|
|
2020
|
168
|
|
71
|
|
||
2021
|
137
|
|
60
|
|
||
2022
|
103
|
|
45
|
|
||
2023
|
72
|
|
39
|
|
||
Thereafter
|
157
|
|
48
|
|
||
Total lease payments
|
798
|
|
324
|
|
||
Less: interest
|
(94
|
)
|
(111
|
)
|
||
Total
|
$
|
704
|
|
$
|
213
|
|
|
At December 31, 2018
|
||
2019
|
$
|
210
|
|
2020
|
168
|
|
|
2021
|
142
|
|
|
2022
|
109
|
|
|
2023
|
80
|
|
|
Thereafter
|
147
|
|
|
|
$
|
856
|
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
1.40% notes due 2019
|
$
|
1,250
|
|
|
$
|
1,250
|
|
Three year floating rate notes due 2019
|
250
|
|
|
250
|
|
||
Two year floating rate notes due 2019
|
450
|
|
|
450
|
|
||
1.80% notes due 2019
|
750
|
|
|
750
|
|
||
0.65% Euro notes due 2020
|
1,123
|
|
|
1,145
|
|
||
4.25% notes due 2021
|
800
|
|
|
800
|
|
||
1.85% notes due 2021
|
1,500
|
|
|
1,500
|
|
||
1.30% Euro notes due 2023
|
1,404
|
|
|
1,432
|
|
||
3.35% notes due 2023
|
300
|
|
|
300
|
|
||
2.50% notes due 2026
|
1,500
|
|
|
1,500
|
|
||
2.25% Euro notes due 2028
|
842
|
|
|
859
|
|
||
5.70% notes due 2036
|
441
|
|
|
441
|
|
||
5.70% notes due 2037
|
462
|
|
|
462
|
|
||
5.375% notes due 2041
|
417
|
|
|
417
|
|
||
3.812% notes due 2047
|
445
|
|
|
445
|
|
||
Industrial development bond obligations, floating rate maturing at various dates through 2037
|
22
|
|
|
22
|
|
||
6.625% debentures due 2028
|
201
|
|
|
201
|
|
||
9.065% debentures due 2033
|
51
|
|
|
51
|
|
||
Other (including capitalized leases and debt issuance costs), 5.2% weighted average maturing at various dates through 2025
|
390
|
|
|
353
|
|
||
|
12,598
|
|
|
12,628
|
|
||
Less: current portion
|
(4,000
|
)
|
|
(2,872
|
)
|
||
|
$
|
8,598
|
|
|
$
|
9,756
|
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
Assets:
|
|
|
|
||||
Foreign currency exchange contracts
|
$
|
180
|
|
|
$
|
119
|
|
Available for sale investments
|
2,214
|
|
|
1,784
|
|
||
Interest rate swap agreements
|
25
|
|
|
20
|
|
||
Cross currency swap agreements
|
45
|
|
|
32
|
|
||
Liabilities:
|
|
|
|
||||
Foreign currency exchange contracts
|
$
|
9
|
|
|
$
|
4
|
|
Interest rate swap agreements
|
46
|
|
|
65
|
|
|
March 31, 2019
|
|
December 31, 2018
|
||||||||||||
|
Carrying
Value
|
|
Fair
Value
|
|
Carrying
Value
|
|
Fair
Value
|
||||||||
Assets
|
|
|
|
|
|
|
|
||||||||
Long-term receivables
|
$
|
343
|
|
|
$
|
336
|
|
|
$
|
333
|
|
|
$
|
329
|
|
Liabilities
|
|
|
|
|
|
|
|
||||||||
Long-term debt and related current maturities
|
$
|
12,598
|
|
|
$
|
13,299
|
|
|
$
|
12,629
|
|
|
$
|
13,133
|
|
Line in the Consolidated Balance Sheet of Hedged Item
|
|
Carrying Amount of the Hedged Item
|
|
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Item
|
||||||||||||
|
March 31, 2019
|
|
December 31, 2018
|
|
March 31, 2019
|
|
December 31, 2018
|
|||||||||
Long-term debt
|
|
$
|
2,579
|
|
|
$
|
2,555
|
|
|
$
|
(21
|
)
|
|
$
|
(45
|
)
|
|
|
|
Three Months Ended
March 31, 2019 |
||||||||||||||||||
|
|
|
Revenue
|
|
Cost of Products Sold
|
|
SG&A
|
|
Other (Income) Expense
|
|
Interest and Other Financial Charges
|
||||||||||
|
$
|
8,884
|
|
|
$
|
4,622
|
|
|
$
|
1,363
|
|
|
$
|
(285
|
)
|
|
$
|
85
|
|
||
Gain or (loss) on cash flow hedges:
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Foreign Currency Exchange Contracts:
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
Amount reclassified from accumulated other comprehensive income into income
|
—
|
|
|
16
|
|
|
—
|
|
|
24
|
|
|
—
|
|
|||||
|
|
Amount excluded from effectiveness testing recognized in earnings using an amortization approach
|
—
|
|
|
6
|
|
|
—
|
|
|
9
|
|
|
—
|
|
|||||
Gain or (loss) on fair value hedges:
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Interest Rate Swap Agreements:
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
Hedged Items
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(24
|
)
|
|||||
|
|
Derivatives designated as hedges
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
24
|
|
|
|
|
Three Months Ended
March 31, 2018 |
||||||||||||||||||
|
|
|
Revenue
|
|
Cost of Products Sold
|
|
SG&A
|
|
Other (Income) Expense
|
|
Interest and Other Financial Charges
|
||||||||||
|
$
|
10,392
|
|
|
$
|
5,905
|
|
|
$
|
1,475
|
|
|
$
|
(268
|
)
|
|
$
|
83
|
|
||
Gain or (loss) on cash flow hedges:
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Foreign Currency Exchange Contracts:
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
Amount reclassified from accumulated other comprehensive income into income
|
(3
|
)
|
|
(22
|
)
|
|
2
|
|
|
—
|
|
|
—
|
|
|||||
Gain or (loss) on fair value hedges:
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Interest Rate Swap Agreements:
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
Hedged Items
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
46
|
|
|||||
|
|
Derivatives designated as hedges
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(46
|
)
|
|
Three Months Ended
March 31, |
|||||
Derivatives Net Investment Hedging Relationships
|
2019
|
2018
|
||||
Euro-denominated long-term debt
|
$
|
68
|
|
$
|
(82
|
)
|
Euro-denominated commercial paper
|
71
|
|
(101
|
)
|
||
Cross currency swap
|
13
|
|
(58
|
)
|
||
Foreign currency exchange contracts
|
7
|
|
—
|
|
|
Foreign
Exchange
Translation
Adjustment
|
|
Pension
and Other
Postretirement
Benefits
Adjustments
|
|
Changes in
Fair Value
of Cash Flow
Hedges
|
|
Total
|
||||||||
Balance at December 31, 2018
|
$
|
(2,709
|
)
|
|
$
|
(761
|
)
|
|
$
|
33
|
|
|
$
|
(3,437
|
)
|
Other comprehensive income (loss) before reclassifications
|
205
|
|
|
—
|
|
|
38
|
|
|
243
|
|
||||
Amounts reclassified from accumulated other comprehensive income
|
—
|
|
|
(19
|
)
|
|
(32
|
)
|
|
(51
|
)
|
||||
Net current period other comprehensive income (loss)
|
205
|
|
|
(19
|
)
|
|
6
|
|
|
192
|
|
||||
Balance at March 31, 2019
|
$
|
(2,504
|
)
|
|
$
|
(780
|
)
|
|
$
|
39
|
|
|
$
|
(3,245
|
)
|
|
Foreign
Exchange
Translation
Adjustment
|
|
Pension
and Other
Postretirement
Benefits
Adjustments
|
|
Changes in
Fair Value
of
Cash Flow
Hedges
|
|
Total
|
||||||||
Balance at December 31, 2017
|
$
|
(1,981
|
)
|
|
$
|
(202
|
)
|
|
$
|
(52
|
)
|
|
$
|
(2,235
|
)
|
Other comprehensive income (loss) before reclassifications
|
91
|
|
|
—
|
|
|
(32
|
)
|
|
59
|
|
||||
Amounts reclassified from accumulated other comprehensive income
|
—
|
|
|
(16
|
)
|
|
18
|
|
|
2
|
|
||||
Net current period other comprehensive income (loss)
|
91
|
|
|
(16
|
)
|
|
(14
|
)
|
|
61
|
|
||||
Balance at March 31, 2018
|
$
|
(1,890
|
)
|
|
$
|
(218
|
)
|
|
$
|
(66
|
)
|
|
$
|
(2,174
|
)
|
|
Three Months Ended
March 31, |
||||||
|
2019
|
|
2018
|
||||
Net sales
|
|
|
|
|
|
||
Aerospace
|
|
|
|
|
|
||
Products
|
$
|
2,075
|
|
|
$
|
2,728
|
|
Services
|
1,266
|
|
|
1,249
|
|
||
Total
|
3,341
|
|
|
3,977
|
|
||
Honeywell Building Technologies
|
|
|
|
||||
Products
|
1,073
|
|
|
2,083
|
|
||
Services
|
316
|
|
|
350
|
|
||
Total
|
1,389
|
|
|
2,433
|
|
||
Performance Materials and Technologies
|
|
|
|
||||
Products
|
2,070
|
|
|
2,063
|
|
||
Services
|
502
|
|
|
471
|
|
||
Total
|
2,572
|
|
|
2,534
|
|
||
Safety and Productivity Solutions
|
|
|
|
||||
Products
|
1,495
|
|
|
1,360
|
|
||
Services
|
87
|
|
|
88
|
|
||
Total
|
1,582
|
|
|
1,448
|
|
||
|
$
|
8,884
|
|
|
$
|
10,392
|
|
Segment profit
|
|
|
|
||||
Aerospace
|
$
|
838
|
|
|
$
|
893
|
|
Honeywell Building Technologies
|
271
|
|
|
416
|
|
||
Performance Materials and Technologies
|
564
|
|
|
519
|
|
||
Safety and Productivity Solutions
|
212
|
|
|
231
|
|
||
Corporate
|
(76
|
)
|
|
(64
|
)
|
||
Total segment profit
|
1,809
|
|
|
1,995
|
|
||
Interest and other financial charges
|
(85
|
)
|
|
(83
|
)
|
||
Stock compensation expense
(a)
|
(41
|
)
|
|
(52
|
)
|
||
Pension ongoing income
(b)
|
151
|
|
|
248
|
|
||
Other postretirement income
(b)
|
12
|
|
|
6
|
|
||
Repositioning and other charges
(c)
|
(84
|
)
|
|
(191
|
)
|
||
Other
(d)
|
80
|
|
|
(12
|
)
|
||
Income before taxes
|
$
|
1,842
|
|
|
$
|
1,911
|
|
|
U.S. Plans
|
||||||
|
Three Months Ended
March 31, |
||||||
|
2019
|
|
2018
|
||||
Service cost
|
$
|
21
|
|
|
$
|
35
|
|
Interest cost
|
153
|
|
|
143
|
|
||
Expected return on plan assets
|
(279
|
)
|
|
(357
|
)
|
||
Amortization of prior service (credit)
|
(11
|
)
|
|
(11
|
)
|
||
|
$
|
(116
|
)
|
|
$
|
(190
|
)
|
|
Non-U.S. Plans
|
||||||
|
Three Months Ended
March 31, |
||||||
|
2019
|
|
2018
|
||||
Service cost
|
$
|
6
|
|
|
$
|
7
|
|
Interest cost
|
36
|
|
|
37
|
|
||
Expected return on plan assets
|
(84
|
)
|
|
(115
|
)
|
||
Amortization of prior service (credit)
|
—
|
|
|
—
|
|
||
|
$
|
(42
|
)
|
|
$
|
(71
|
)
|
December 31, 2018
|
$
|
755
|
|
Accruals for environmental matters deemed probable and reasonably estimable
|
86
|
|
|
Environmental liability payments
|
(28
|
)
|
|
Other
|
(1
|
)
|
|
March 31, 2019
|
$
|
812
|
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
Accrued liabilities
|
$
|
175
|
|
|
$
|
175
|
|
Other liabilities
|
637
|
|
|
580
|
|
||
|
$
|
812
|
|
|
$
|
755
|
|
Asbestos-Related Liabilities
|
|
|
|
|
|
||||||
|
Bendix
|
|
NARCO
|
|
Total
|
||||||
December 31, 2018
|
$
|
1,623
|
|
|
$
|
891
|
|
|
$
|
2,514
|
|
Accrual for update to estimated liability
|
15
|
|
|
6
|
|
|
21
|
|
|||
Asbestos related liability payments
|
(44
|
)
|
|
—
|
|
|
(44
|
)
|
|||
March 31, 2019
|
$
|
1,594
|
|
|
$
|
897
|
|
|
$
|
2,491
|
|
Insurance Recoveries for Asbestos-Related Liabilities
|
|
|
|
|
|
|
|
|
|||
|
Bendix
|
|
NARCO
|
|
Total
|
||||||
December 31, 2018
|
$
|
170
|
|
|
$
|
307
|
|
|
$
|
477
|
|
Insurance receipts for asbestos related liabilities
|
(2
|
)
|
|
(6
|
)
|
|
(8
|
)
|
|||
March 31, 2019
|
$
|
168
|
|
|
$
|
301
|
|
|
$
|
469
|
|
|
March 31,
|
|
December 31,
|
||||
|
2019
|
|
2018
|
||||
Other current assets
|
$
|
40
|
|
|
$
|
40
|
|
Insurance recoveries for asbestos related liabilities
|
429
|
|
|
437
|
|
||
|
$
|
469
|
|
|
$
|
477
|
|
Accrued liabilities
|
$
|
245
|
|
|
$
|
245
|
|
Asbestos related liabilities
|
2,246
|
|
|
2,269
|
|
||
|
$
|
2,491
|
|
|
$
|
2,514
|
|
(i)
|
liability for unasserted claims; and
|
(ii)
|
liability for claims asserted after the NARCO Trust became operational but not yet paid.
|
|
Three Months Ended
March 31, |
|
Years Ended
December 31, |
|||||
Claims Activity
|
2019
|
|
2018
|
|
2017
|
|||
Claims unresolved at the beginning of period
|
6,209
|
|
|
6,280
|
|
|
7,724
|
|
Claims filed
|
631
|
|
|
2,430
|
|
|
2,645
|
|
Claims resolved
|
(626
|
)
|
|
(2,501
|
)
|
|
(4,089
|
)
|
Claims unresolved at the end of period
|
6,214
|
|
|
6,209
|
|
|
6,280
|
|
Disease Distribution of Unresolved Claims
|
March 31,
|
|
December 31,
|
|||||
|
2019
|
|
2018
|
|
2017
|
|||
Mesothelioma and other cancer claims
|
3,028
|
|
|
2,949
|
|
|
3,062
|
|
Nonmalignant claims
|
3,186
|
|
|
3,260
|
|
|
3,218
|
|
Total claims
|
6,214
|
|
|
6,209
|
|
|
6,280
|
|
|
Years Ended December 31,
|
||||||||||||||||||
|
2018
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
||||||||||
|
(in whole dollars)
|
||||||||||||||||||
Malignant claims
|
$
|
55,300
|
|
|
$
|
56,000
|
|
|
$
|
44,000
|
|
|
$
|
44,000
|
|
|
$
|
53,500
|
|
Nonmalignant claims
|
$
|
4,700
|
|
|
$
|
2,800
|
|
|
$
|
4,485
|
|
|
$
|
100
|
|
|
$
|
120
|
|
ITEM 2.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
|
|
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (MD&A)
|
|
(Dollars in millions, except per share amounts)
|
A.
|
Results of Operations – three months ended March 31, 2019 compared with the three months ended March 31, 2018
|
Net Sales
|
|
||||||
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
Net sales
|
$
|
8,884
|
|
|
$
|
10,392
|
|
% change compared with prior period
|
(15
|
)%
|
|
|
|
|
Three Months
|
|
Volume
|
6
|
%
|
Price
|
2
|
%
|
Foreign Currency Translation
|
(3
|
)%
|
Acquisitions/Divestitures
|
(20
|
)%
|
|
(15
|
)%
|
Cost of Products and Services Sold
|
|
|
|
||||
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
Cost of products and services sold
|
$
|
5,879
|
|
|
$
|
7,191
|
|
% change compared with prior period
|
(18
|
)%
|
|
|
|
||
Gross margin percentage
|
33.8
|
%
|
|
30.8
|
%
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
Selling, general and administrative expense
|
$
|
1,363
|
|
|
$
|
1,475
|
|
% of sales
|
15.3
|
%
|
|
14.2
|
%
|
Other (Income) Expense
|
|
|
|
||||
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
Other (income) expense
|
$
|
(285
|
)
|
|
$
|
(268
|
)
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
Tax expense (benefit)
|
$
|
406
|
|
|
$
|
459
|
|
Effective tax rate
|
22.0
|
%
|
|
24.0
|
%
|
|
Three Months Ended March 31,
|
||||||
|
2019
|
|
2018
|
||||
Net income attributable to Honeywell
|
$
|
1,416
|
|
|
$
|
1,439
|
|
Earnings per share of common stock – assuming dilution
|
$
|
1.92
|
|
|
$
|
1.89
|
|
|
Three Months Ended March 31,
|
|||||||||
|
2019
|
|
2018
|
|
%
Change
|
|||||
Aerospace sales
|
|
|
|
|
|
|||||
Commercial Aviation Original Equipment
|
$
|
759
|
|
|
$
|
695
|
|
|
9
|
%
|
Commercial Aviation Aftermarket
|
1,361
|
|
|
1,268
|
|
|
7
|
%
|
||
Defense and Space
|
1,221
|
|
|
1,086
|
|
|
12
|
%
|
||
Transportation Systems
|
—
|
|
|
928
|
|
|
(100
|
)%
|
||
Total Aerospace sales
|
3,341
|
|
|
3,977
|
|
|
|
|||
Honeywell Building Technologies sales
|
|
|
|
|
|
|||||
Homes
|
—
|
|
|
1,157
|
|
|
(100
|
)%
|
||
Buildings
|
1,389
|
|
|
1,276
|
|
|
9
|
%
|
||
Total Honeywell Building Technologies sales
|
1,389
|
|
|
2,433
|
|
|
|
|||
Performance Materials and Technologies sales
|
|
|
|
|
|
|||||
UOP
|
610
|
|
|
612
|
|
|
—
|
%
|
||
Process Solutions
|
1,246
|
|
|
1,214
|
|
|
3
|
%
|
||
Advanced Materials
|
716
|
|
|
708
|
|
|
1
|
%
|
||
Total Performance Materials and Technologies sales
|
2,572
|
|
|
2,534
|
|
|
|
|||
Safety and Productivity Solutions sales
|
|
|
|
|
|
|||||
Safety
|
538
|
|
|
551
|
|
|
(2
|
)%
|
||
Productivity Solutions
|
1,044
|
|
|
897
|
|
|
16
|
%
|
||
Total Safety and Productivity Solutions sales
|
1,582
|
|
|
1,448
|
|
|
|
|||
Net sales
|
$
|
8,884
|
|
|
$
|
10,392
|
|
|
|
|
Three Months Ended
March 31,
|
|||||||||
|
2019
|
|
2018
|
|
%
Change
|
|||||
Net sales
|
$
|
3,341
|
|
|
$
|
3,977
|
|
|
(16
|
)%
|
Cost of products and services sold
|
2,232
|
|
|
2,790
|
|
|
|
|||
Selling, general and administrative and other expenses
|
271
|
|
|
294
|
|
|
|
|||
Segment profit
|
$
|
838
|
|
|
$
|
893
|
|
|
(6
|
)%
|
|
2019 vs. 2018
|
||||
|
Three Months Ended
March 31,
|
||||
Factors Contributing to Year-Over-Year Change
|
Sales
|
|
Segment
Profit
|
||
Organic growth/ Operational segment profit
|
10
|
%
|
|
19
|
%
|
Foreign currency translation
|
—
|
%
|
|
(1
|
)%
|
Acquisitions, divestitures and other, net
|
(26
|
)%
|
|
(24
|
)%
|
Total % change
|
(16
|
)%
|
|
(6
|
)%
|
•
|
Commercial Aviation Original Equipment sales increased
9%
(increased 10% organic) primarily due to increased demand from business aviation customers.
|
•
|
Commercial Aviation Aftermarket sales increased
7%
(increased 8% organic) with growth in both air transport and regional, and business aviation.
|
•
|
Defense and Space sales increased
12%
(increased 13% organic) primarily driven by growth in U.S. and international defense.
|
|
Three Months Ended
March 31,
|
|||||||||
|
2019
|
|
2018
|
|
% Change
|
|||||
Net sales
|
$
|
1,389
|
|
|
$
|
2,433
|
|
|
(43
|
)%
|
Cost of products and services sold
|
846
|
|
|
1,586
|
|
|
|
|||
Selling, general and administrative and other expenses
|
272
|
|
|
431
|
|
|
|
|||
Segment profit
|
$
|
271
|
|
|
$
|
416
|
|
|
(35
|
)%
|
|
2019 vs. 2018
|
||||
|
Three Months Ended
|
||||
|
March 31,
|
||||
Factors Contributing to Year-Over-Year Change
|
Sales
|
|
Segment
Profit
|
||
Organic growth/ Operational segment profit
|
9
|
%
|
|
7
|
%
|
Foreign currency translation
|
(3
|
)%
|
|
(3
|
)%
|
Acquisitions, divestitures and other, net
|
(49
|
)%
|
|
(39
|
)%
|
Total % change
|
(43
|
)%
|
|
(35
|
)%
|
•
|
Sales in Building Technologies, excluding the Homes divestiture and related impacts, increased 9% (increased 9% organic) primarily due to higher organic sales growth in Building Solutions and Products.
|
|
Three Months Ended
March 31,
|
|||||||||
|
2019
|
|
2018
|
|
%
Change
|
|||||
Net sales
|
$
|
2,572
|
|
|
$
|
2,534
|
|
|
2
|
%
|
Cost of products and services sold
|
1,648
|
|
|
1,681
|
|
|
|
|
||
Selling, general and administrative and other expenses
|
360
|
|
|
334
|
|
|
|
|
||
Segment profit
|
$
|
564
|
|
|
$
|
519
|
|
|
9
|
%
|
|
2019 vs. 2018
|
||||
|
Three Months Ended
March 31,
|
||||
Factors Contributing to Year-Over-Year Change
|
Sales
|
|
Segment
Profit
|
||
Organic growth/ Operational segment profit
|
5
|
%
|
|
11
|
%
|
Foreign currency translation
|
(3
|
)%
|
|
(3
|
)%
|
Acquisitions, divestitures and other, net
|
—
|
%
|
|
1
|
%
|
Total % change
|
2
|
%
|
|
9
|
%
|
•
|
UOP sales were flat (increased 1% organic) driven primarily by higher gas processing project revenues, offset primarily by decreases in catalyst shipments and in engineering revenues.
|
•
|
Process Solutions sales increased 3% (increased 7% organic) driven primarily by increases in maintenance and migration services and in projects, partially offset by decreases in smart energy.
|
•
|
Advanced Materials sales increased 1% (increased 4% organic) driven primarily by increases in fluorine products, partially offset by decreases in specialty products.
|
|
Three Months Ended
March 31, |
|||||||||
|
2019
|
|
2018
|
|
%
Change
|
|||||
Net sales
|
$
|
1,582
|
|
|
$
|
1,448
|
|
|
9
|
%
|
Cost of products and services sold
|
1,079
|
|
|
949
|
|
|
|
|
||
Selling, general and administrative and other expenses
|
291
|
|
|
268
|
|
|
|
|
||
Segment profit
|
$
|
212
|
|
|
$
|
231
|
|
|
(8
|
)%
|
|
2019 vs. 2018
|
||||
|
Three Months Ended
March 31, |
||||
Factors Contributing to Year-Over-Year Change
|
Sales
|
|
Segment
Profit
|
||
Organic growth/ Operational segment profit
|
10
|
%
|
|
(7
|
)%
|
Foreign currency translation
|
(3
|
)%
|
|
(2
|
)%
|
Acquisitions, divestitures, and other, net
|
2
|
%
|
|
1
|
%
|
Total % change
|
9
|
%
|
|
(8
|
)%
|
•
|
Sales in Safety decreased 2% (flat organic) primarily due to the unfavorable impact of foreign exchange in industrial safety partially offset by an increase in retail sales volume.
|
•
|
Sales in Productivity Solutions increased 16% (increased 15% organic) primarily due to increased organic sales volume in warehouse automation and Sensing and IoT, partially offset by decreased organic sales volume in Productivity Products.
|
B.
|
Liquidity and Capital Resources
|
|
Three Months Ended
March 31,
|
||||||
|
2019
|
|
2018
|
||||
Cash provided by (used for):
|
|
|
|
|
|
||
Operating activities
|
$
|
1,134
|
|
|
$
|
1,136
|
|
Investing activities
|
(609
|
)
|
|
994
|
|
||
Financing activities
|
(1,235
|
)
|
|
(1,448
|
)
|
||
Effect of exchange rate changes on cash
|
48
|
|
|
156
|
|
||
Net (decrease) increase in cash and cash equivalents
|
$
|
(662
|
)
|
|
$
|
838
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risks
|
Item 4.
|
Controls and Procedures
|
Item 1.
|
Legal Proceedings
|
|
|
|
General Legal Matters
|
|
Environmental Matters Involving Potential Monetary Sanctions in Excess of $100,000
|
Item 1A.
|
Risk Factors
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
Issuer Purchases of Equity Securities
|
|||||||||||||
|
(a)
|
|
(b)
|
|
(c)
|
|
(d)
|
||||||
Period
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Approximate Dollar Value of Shares that May Yet be Purchased Under Plans or Programs (Dollars in millions)
|
||||||
January 2019
|
1,728,710
|
|
|
$
|
138.83
|
|
|
1,728,710
|
|
|
$
|
3,497
|
|
February 2019
|
867,877
|
|
|
$
|
149.77
|
|
|
867,877
|
|
|
$
|
3,367
|
|
March 2019
|
2,456,461
|
|
|
$
|
154.67
|
|
|
2,456,461
|
|
|
$
|
2,987
|
|
Item 6.
|
Exhibits
|
Exhibit
No.
|
|
Description
|
|
10.1*
|
|
|
|
|
|
|
|
31.1
|
|
|
|
|
|
|
|
31.2
|
|
|
|
|
|
|
|
32.1
|
|
|
|
|
|
|
|
32.2
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document (filed herewith)
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema (filed herewith)
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase (filed herewith)
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase (filed herewith)
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase (filed herewith)
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase (filed herewith)
|
|
Honeywell International Inc.
|
|
|
|
|
Date: April 18, 2019
|
By:
|
/s/ John J. Tus
|
|
|
John J. Tus
Vice President and Controller
(on behalf of the Registrant
and as the Registrant’s
Principal Accounting Officer)
|
|
•
|
Excess Liability Insurance
: Honeywell will pay the annual premium for an Excess Liability Insurance policy that provides $10,000,000 of personal umbrella coverage per occurrence.
|
•
|
Executive Severance
: The Honeywell International Inc. Severance Plan for Designated Officers currently provides for 36 months of base salary continuation and target bonus if your employment is involuntary terminated for a reason other than Cause (as defined in the severance plan document in
|
1.
|
Records of Inventions.
I will keep complete and current written records of all Inventions I Make during the period of time I am employed by Honeywell and promptly disclose all such Inventions in writing to Honeywell for the purpose of adequately determining Honeywell’s rights in each such Invention. I will supplement any such disclosures to the extent Honeywell may request that I do so. If I have any doubt as to whether or not to disclose an Invention to Honeywell, I will disclose it.
|
2.
|
Disclosure of Inventions after Termination.
I will promptly and completely disclose in writing to Honeywell’s Law Department all Inventions which I Make during the one year immediately following the end of my employment by Honeywell which relate either to my work assignment at Honeywell or to Honeywell’s Trade Secrets, Proprietary and Confidential Information for the purpose of determining Honeywell’s rights in each such Invention before filing any application for patents on such Inventions. I will not file any patent application relating to any such Invention without the prior written consent of Honeywell’s Law Department. If I do not prove that I Made the Invention entirely after leaving Honeywell’s employment, the Invention is presumed to have been Made during the period of time I was employed by Honeywell. I acknowledge that the conditions of this paragraph are no greater than is necessary for protecting Honeywell’s interests in Honeywell’s Trade Secrets, Proprietary and Confidential Information and in Inventions to which it is rightfully entitled.
|
3.
|
Ownership of Inventions.
Each and every Invention I Make during the period of time I am employed by Honeywell (a) which relates directly to the business of Honeywell or to Honeywell’s actual or demonstrably anticipated research or development, or (b) which results from any work I perform for Honeywell is the sole and exclusive property of Honeywell, and I agree to assign and hereby assign my entire right, title and interest in each such Invention to Honeywell. Each Invention I Make during the period of time I am employed by Honeywell for which no equipment, supplies, facilities or Honeywell Trade Secrets, Proprietary or Confidential Information was used and which was developed entirely on my own time is my property, unless (a) the Invention relates directly to the business of Honeywell or to Honeywell’s actual or demonstrably anticipated research or development, or (b) the Invention results from any work performed by me for Honeywell. If I assert any property right in an Invention I Make during the period of time I am employed by Honeywell, I will promptly notify Honeywell’s Law Department in writing.
|
4.
|
Cooperation with Honeywell.
I will assist and fully cooperate with Honeywell in obtaining, maintaining, and asserting the fullest measure of legal protection, which Honeywell elects to obtain, maintain or assert for Inventions in which it has a property right. I will also assist and fully cooperate with Honeywell in defending Honeywell against claims of violation of the intellectual property rights of others. I will be paid my reasonable expenses in assisting, and cooperating with, Honeywell. I will execute any lawful document Honeywell requests me to execute relating to obtaining, maintaining, or asserting legal protection for any said Invention or in defending against claims of the violation of the intellectual property rights of others (including, but not limited to, executing applications, assignments, oaths, declarations, and affidavits) and I will make myself available for interviews, depositions and testimony. In the event that Honeywell is unable, after reasonable effort, to secure my signature on any document or documents needed to apply for or prosecute any patent, copyright, or other
|
5.
|
Pre-employment Inventions.
On Schedule A, which is an integral part of this agreement, I have completely identified (without disclosing any trade secret, proprietary or other confidential information) every Invention I Made before my employment by Honeywell in which I have an ownership interest and which is not the subject matter of an issued patent or a printed publication at the time I sign this agreement. If I become aware of any projected or actual use of any such Invention by Honeywell, I will promptly notify Honeywell in writing of said use. Except as to the Inventions listed on Schedule A or those which are the subject matter of an issued patent or a printed publication at the time I sign this agreement, I will not assert any rights against Honeywell with respect to any Invention Made before my employment by Honeywell.
|
6.
|
Honeywell’s Trade Secrets, Proprietary and Confidential Information.
I will never, directly or indirectly, during or after my employment with Honeywell misappropriate, use or disclose Honeywell’s Trade Secrets, Proprietary and Confidential Information except in furthering Honeywell’s business nor will I disclose or disseminate at any time Honeywell’s Trade Secrets, Proprietary and Confidential Information to anyone who is not an officer, director, employee, attorney or authorized agent of Honeywell without the prior written consent of Honeywell’s Law Department unless the specific item of Honeywell’s Trade Secrets, Proprietary and Confidential Information: (a) is now in, or hereafter, (through no breach of this agreement) becomes general public knowledge, or (b) prior to my disclosure, dissemination or use, was lawfully acquired by me without any obligation to retain the information in confidence. In this connection, I will not publish any of Honeywell’s Trade Secrets, Proprietary and Confidential Information for dissemination outside Honeywell or file any patent application relating to any Invention I Make during the period of time I am employed by Honeywell without the prior written approval of Honeywell’s Law Department. I will execute any agreement relating to the protection of Honeywell’s Trade Secrets, Proprietary and Confidential Information or such information of any third party whose intellectual property Honeywell is under a legal obligation to protect if Honeywell requests that I do so. I will not engage without the prior written consent of Honeywell’s Law Department, either during the period of time I am employed by Honeywell or for a period of two years following my Termination of Employment for any reason, in any activity or employment in the faithful performance of which it could be reasonably anticipated that I would use or disclose Honeywell’s Trade Secrets, Proprietary and Confidential Information. All documents and tangible things embodying or containing Honeywell’s Trade Secrets, Proprietary and Confidential Information are Honeywell’s exclusive property. I have access to them solely for performing the duties of my employment by Honeywell. I will protect the confidentiality of their content and comply with all security policies and procedures, which may, from time to time, be established by Honeywell. I will return all of them and all copies, facsimiles and specimens of them and any other tangible forms of Honeywell’s Trade Secrets, Proprietary and Confidential Information in my possession, custody or control to Honeywell before leaving the employment of Honeywell.
|
7.
|
Trade Secrets, Proprietary or Confidential Information from Previous Employment.
I certify that I have not, and will not, disclose or use during my employment by Honeywell, any trade secrets, proprietary or
|
8.
|
Prior Restrictive Obligation.
On Schedule B, which is an integral part of this agreement, I have completely identified all prior obligations (written and oral), which restrict my ability to perform the duties of my employment by Honeywell, including all confidentiality agreements and covenants restricting future employment.
|
9.
|
Nonsolicitation of Honeywell Employees.
I acknowledge that Honeywell has invested, and will continue to invest, significant time and money to recruit and retain its employees. Therefore, recognizing that in the course of my employment I have obtained valuable information about Honeywell employees, their respective talents and areas of expertise, I agree that, during my employment and for a period of two (2) years following my Termination of Employment from Honeywell for any reason, I will not directly or indirectly, for my own account or for others, (i) solicit (or assist another in soliciting) for employment or for the performance of services, (ii) offer or cause to be offered employment or other service engagement, or (iii) participate in any manner in the employment or hiring for services of any current or former Honeywell employee with whom I had contact or of whom I became aware in my last two years of Honeywell employment, unless it has been more than 12 months since that individual left Honeywell. Nor will I, for my own account or for others, in any way induce or attempt to induce such individual to leave the employment of Honeywell.
|
10.
|
Nonsolicitation of Honeywell Customers, Suppliers, Business Partners and Vendors.
I acknowledge that Honeywell has invested and will continue to invest significant time and money to develop valuable, continuing relationships with existing and prospective clients and customers of Honeywell. Therefore, recognizing that in the course of my employment I have obtained valuable information about Honeywell customers, suppliers, business partners, and/or vendors, and their requirements, I agree that during my employment and for a period of two (2) years following my Termination of Employment from Honeywell for any reason, I will not directly or indirectly, for my own account or for others, solicit or assist others in soliciting or attempt to solicit (or assist others in attempting to solicit), (i) any existing clients, customers, suppliers, business partners, and/or vendors of Honeywell with whom I had contact, or of whom I became aware while employed by Honeywell during the two-year period prior to my Termination of Employment, or (ii) any prospective clients, customers, suppliers, business partners, and/or vendors of Honeywell with whom I had contact and with whom Honeywell took significant steps to do business during the two-year period prior to my Termination of Employment, for the purpose of inducing such existing or prospective clients, customers, suppliers, business partners, and/or vendors to cease doing business or reduce their business with Honeywell or to purchase, lease or utilize products or services that are competitive with, similar to, or that may be used as substitutes for any products or services offered by Honeywell.
|
11.
|
Notice to Future Employers.
For the period of two (2) years immediately following the end of my employment by Honeywell, I will inform each new employer, prior to accepting employment, of the existence of this agreement and provide that employer with a copy of it. Honeywell has the right to inform any future employer of the existence of this agreement and to provide any future employers with a copy of it.
|
12.
|
Copyright.
As to all works prepared by me which are: (i) within the scope of my employment, or (ii) based upon information I acquired from Honeywell which is not normally made available to the public, or (iii) commissioned by Honeywell, but not within my scope of employment, I hereby agree to:
|
(a)
|
Submit to Honeywell’s Law Department and to my supervisor for approval for publication or oral dissemination;
|
(b)
|
Assign all right, title and interest in and to the copyright in all such works to Honeywell; and
|
(c)
|
Waive any claim of moral rights, author’s rights, droit moral, or any equivalent rights to the extent necessary or permitted by law.
|
13.
|
Acknowledgement of Receipt.
I acknowledge that I have received a copy of this agreement prior to accepting employment, continued employment or other consideration as recited herein and that execution of this agreement was an express condition of my employment, continued employment or receipt of other consideration recited herein.
|
14.
|
Effectiveness of Agreement.
I acknowledge that the provisions of this agreement are in addition to, and in no way intended to limit, restrict or narrow any prior or existing agreement with Honeywell. This agreement does not replace or supersede any prior or existing employment or other agreement with Honeywell, but rather, shall be read in conjunction with such prior or existing agreements and shall be interpreted in a manner to provide Honeywell the maximum protection and the most effective and complete assignment of inventions provided by all agreements I have with Honeywell. The terms of this agreement are to be read consistent with the terms of any other intellectual property, trade secret or confidentiality agreements that I have executed with Honeywell; provided, however, to the extent there is a conflict between/among such agreements, such agreements shall be read in concert and construed as providing the broadest possible protections to Honeywell, even if such construction would require provisions of more than one such agreement to be given effect. This agreement shall be deemed effective as of the first day of my employment by Honeywell and shall continue throughout the entire period of time I am employed by Honeywell and my obligations will continue after, and survive, the end of my employment by Honeywell.
|
15.
|
Identity of Future Employer.
Upon termination of my employment for any reason, if reasonably requested by Honeywell, I shall advise Honeywell of the name and address of my intended future employer.
|
16.
|
Remedies.
I acknowledge that a remedy at law for any breach or threatened breach of the provisions of this Agreement would be inadequate and therefore agree that Honeywell shall be entitled to injunctive relief in case of any such breach or threatened breach. In the event that a court determines that I have breached or threatened to breach this agreement, I agree to reimburse Honeywell for all attorneys’ fees and costs incurred in enforcing the terms of the agreement. However, nothing contained herein shall be construed as prohibiting Honeywell from pursuing any other remedies available for any such breach or threatened breach against me or my then-current employer which may also include but not be limited to contract damages, lost profits and punitive damages.
|
17.
|
Successors; Binding Agreement.
This agreement binds my heirs, executors, administrators, legal representatives and assigns and inures to the benefit of Honeywell and its successors and assigns. Only a written amendment executed by both Honeywell and me can modify this agreement.
|
18.
|
Governing Law.
This agreement shall be governed by and construed in accordance with the laws of the State of New Jersey without regard to its principles of conflicts of law.
|
19.
|
Validity.
It is the desire and intent of the parties hereto that the provisions of this agreement shall be enforced to the fullest extent legally-permissible. Accordingly, if any particular provision(s) of this agreement shall be adjudicated to be invalid or unenforceable, the court may modify or sever such provision(s), such modification or deletion to apply only with respect to the operation of such provision(s) in the particular jurisdiction in which such adjudication is made. In addition, if any one or more of the provisions contained in this agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it shall be
|
20.
|
Definitions
|
(a)
|
“Honeywell” collectively identifies Honeywell International Inc. (a Delaware corporation having a place of business at Tabor Road, Morris Plains, Morris County, New Jersey), its predecessors, designees and successors and its past, present and future operating companies, divisions, subsidiaries, affiliates and other business units, including businesses acquired by purchase of stock, merger or otherwise.
|
(b)
|
“Trade Secrets, Proprietary and Confidential Information” means information which is not generally known in the industry in which Honeywell is engaged, which may be disclosed to me or which I may learn, observe, discover or otherwise acquire during, or as a result of, my employment by Honeywell and which includes, without limitation, any information, whether patentable, patented or not, relating to any existing or contemplated products, inventions, services, technology, ideas, concepts, designs, patterns, processes, compounds, formulae, programs, devices, tools, compilations of information, methods, techniques, and including information relating to any research, development, manufacture, purchasing, engineering, know-how, business plans, sales or market methods, methods of doing business, customer lists, customer usages or requirements, or supplier information, which is owned or licensed by Honeywell or held by Honeywell in confidence.
|
(c)
|
“Invention” includes not only inventions (whether or not patentable), but also innovations, improvements, discoveries, ideas and all other forms of intellectual property (including, but not limited to, copyright works and mask works) - whether or not any of the foregoing constitutes trade secret or other confidential information.
|
(d)
|
“Make” or “Made” when used in relation to Invention includes any one or any combination of (i) conception, (ii) reduction to practice, or (iii) development of an Invention and is without regard to whether I am a sole or joint inventor.
|
(e)
|
“Termination of Employment” shall be defined as any separation from employment with Honeywell regardless of the reason, including any and all voluntary and involuntary reasons for termination. The termination date for purposes of this Agreement shall be the last day I actively perform services for Honeywell.
|
(f)
|
“Solicit” or “soliciting” includes contacting, communicating with, marketing to, engaging or otherwise interacting with (whether initiated by me or not).
|
21.
|
Headings Descriptive.
The headings of the several paragraphs of this agreement are inserted for convenience only and shall not in any way affect the meaning or construction of this agreement.
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Honeywell International Inc.;
|
|
|
|
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
|
|
|
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
|
|
|
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
|
|
|
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
|
|
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
|
|
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
|
|
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;
|
|
|
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
|
|
|
|
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
|
|
|
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: April 18, 2019
|
By:
|
/s/ Darius Adamczyk
|
|
|
Darius Adamczyk
|
|
|
Chairman and Chief Executive Officer
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Honeywell International Inc.;
|
|
|
|
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
|
|
|
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
|
|
|
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
|
|
|
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
|
|
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
|
|
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
|
|
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;
|
|
|
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
|
|
|
|
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
|
|
|
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: April 18, 2019
|
By:
|
/s/ Gregory P. Lewis
|
|
|
Gregory P. Lewis
|
|
|
Senior Vice President and Chief Financial Officer
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: April 18, 2019
|
By:
|
/s/ Darius Adamczyk
|
|
|
Darius Adamczyk
|
|
|
Chairman and Chief Executive Officer
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: April 18, 2019
|
By:
|
/s/ Gregory P. Lewis
|
|
|
Gregory P. Lewis
|
|
|
Senior Vice President and Chief Financial Officer
|